Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Sep 6;7(36):58543-58552.
doi: 10.18632/oncotarget.10148.

Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis

Affiliations
Meta-Analysis

Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis

Yuchong Yang et al. Oncotarget. .

Abstract

The preoperative prognostic nutritional index (PNI) may forecast colorectal cancer (CRC) outcomes, but the evidence is not conclusive. Here, we retrospectively analyzed a cohort of patients from the Department of Surgical Oncology at the First Hospital of China Medical University (CMU-SO). We also conducted a meta-analysis of eleven cohort studies. Bayesian Information Criterion (BIC) was used to determine the optimal PNI cut-off values for classifying prognosis in the patients from the CMU-SO. The result from CMU-SO and meta-analysis both confirmed that low PNI was significantly associated with a poor prognosis and advanced TNM stages. Among the patients from the CMU-SO, the optimal cut-off values were "41-45-58" (PNI < 41, 41 ≤ PNI < 45, 45 ≤ PNI < 58, PNI ≥ 58), which divided patients into 4 stages. The BIC value for TNM staging combined with the PNI was smaller than that of TNM staging alone (-325.76 vs. -310.80). In conclusion, low PNI was predictive of a poor prognosis and was associated with clinicopathological features in patients with CRC, and the 41-45-58 four-stage division may be suitable for determining prognosis. PNI may thus provide an additional index for use along with the current TNM staging system to determine more accurate CRC prognoses.

Keywords: TNM staging; colorectal cancer; meta-analysis; prognosis; prognostic nutritional index.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1. Kaplan-Meier analysis of survival based on low and high prognostic nutritional index among patients from CMU-SO
A. overall survival; B. cancer-specific survival.
Figure 2
Figure 2. Kaplan-Meier analysis of the overall survival (OS) and cancer-specific survival (CSS) based on low and high prognostic nutritional index among patients from CMU-SO with stage I
(A., OS, P = 0.101; CSS, P = 0.002), stage II (B., OS, P < 0.001; CSS, P < 0.001), stage III (C., OS, P = 0.046; CSS, P = 0.058) and stage IV (D., OS, P = 0.757; CSS, P = 0.841).
Figure 3
Figure 3. Meta-analysis of the association between low prognostic nutritional index and survival in CRC
A. overall survival; B. cancer-specific survival.
Figure 4
Figure 4. The smallest Bayesian Information Criterion values of overall survival and cancer-specific survival for a different number of stage divisions (from two to five divisions)
Figure 5
Figure 5. Kaplan-Meier analysis of the overall survival (OS) and cancer-specific survival (CSS) for a different number of stage divisions which indicated smallest Bayesian Information Criterion value (two-stage division see Figure 1)
A. 41-46 three-stage division; B. 41-45-58 four-stage division; C. five-stage division (OS, 35-41-45-57 four-stage division; CSS, 35-41-46-58 four-stage division)

References

    1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics 2012. CA Cancer J Clin. 2015;65:87–108. - PubMed
    1. De Stefano A, Moretto R, Bucci L, Pepe S, Romano FJ, Cella AC, Attademo L, Rosanova M, De Falco S, Fiore G, Raimondo L, De Placido S, Carlomagno C. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when and for whom? Clinical colorectal cancer. 2014;13:185–191. - PubMed
    1. Papamichael D, Audisio RA, Glimelius B, de Gramont A, Glynne-Jones R, Haller D, Kohne CH, Rostoft S, Lemmens V, Mitry E, Rutten H, Sargent D, Sastre J, Seymour M, Starling N, Van Cutsem E, et al. Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Annals of oncology. 2015;26:463–476. - PubMed
    1. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–444. - PubMed
    1. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–545. - PubMed

Publication types